NanOlogy
Pre-clinicalAiming to Improve the Treatment of Solid Tumors NanOlogy is advancing a local precision approach aimed at improving the treatment of solid tumors without adding toxicity and enabled by the PurcisionTM particle engineering technology that forms unique drug microparticles designed for intratumoral delivery. The patented large surface area microparticles (LSAMs) of pure drug remain at […]
Private Company
Total funding raised: $75M
About
Aiming to Improve the Treatment of Solid Tumors NanOlogy is advancing a local precision approach aimed at improving the treatment of solid tumors without adding toxicity and enabled by the PurcisionTM particle engineering technology that forms unique drug microparticles designed for intratumoral delivery. The patented large surface area microparticles (LSAMs) of pure drug remain at […]